152 related articles for article (PubMed ID: 38680713)
1. The Effect of Tumor Resection and Radiotherapy on the Expression of Stem Cell Markers (CD44 and CD133) in Patients with Squamous Cell Carcinoma.
Paya L; Rafat A; Talebi M; Aghbali A; Shahidi N; Nejati B; Emamverdizadeh P; Nozad Charoudeh H
Int J Hematol Oncol Stem Cell Res; 2024 Jan; 18(1):92-99. PubMed ID: 38680713
[No Abstract] [Full Text] [Related]
2. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
4. Relationship between CD44
Silva Galbiatti-Dias AL; Fernandes GMM; Castanhole-Nunes MMU; Hidalgo LF; Nascimento Filho CHV; Kawasaki-Oyama RS; Ferreira LAM; Biselli-Chicote PM; Pavarino ÉC; Goloni-Bertollo EM
Am J Cancer Res; 2018; 8(8):1633-1641. PubMed ID: 30210931
[TBL] [Abstract][Full Text] [Related]
5. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
[TBL] [Abstract][Full Text] [Related]
6. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
[TBL] [Abstract][Full Text] [Related]
8. FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin.
McDermott SC; Rodriguez-Ramirez C; McDermott SP; Wicha MS; Nör JE
Oncotarget; 2018 May; 9(38):25148-25165. PubMed ID: 29861860
[TBL] [Abstract][Full Text] [Related]
9. CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field.
Su Z; Liu D; Chen L; Zhang J; Ru L; Chen Z; Gao Z; Wang X
Int J Nanomedicine; 2019; 14():7549-7560. PubMed ID: 31571863
[TBL] [Abstract][Full Text] [Related]
10. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of CD133
Wang J; Wu Y; Gao W; Li F; Bo Y; Zhu M; Fu R; Liu Q; Wen S; Wang B
J Cancer; 2017; 8(3):497-506. PubMed ID: 28261352
[No Abstract] [Full Text] [Related]
13. ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas.
Huang C; Yoon C; Zhou XH; Zhou YC; Zhou WW; Liu H; Yang X; Lu J; Lee SY; Huang K
Cell Death Dis; 2020 Apr; 11(4):266. PubMed ID: 32327629
[TBL] [Abstract][Full Text] [Related]
14. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
[TBL] [Abstract][Full Text] [Related]
16. Characterization of FaDu-R, a radioresistant head and neck cancer cell line, and cancer stem cells.
Cho KJ; Park EJ; Kim MS; Joo YH
Auris Nasus Larynx; 2018 Jun; 45(3):566-573. PubMed ID: 28844650
[TBL] [Abstract][Full Text] [Related]
17. Targeting HIF-1α/NOTCH1 pathway eliminates CD44
Byun JY; Huang K; Lee JS; Huang W; Hu L; Zheng X; Tang X; Li F; Jo DG; Song X; Huang C
Oncogene; 2022 Feb; 41(9):1352-1363. PubMed ID: 35013621
[TBL] [Abstract][Full Text] [Related]
18. Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells.
Chikamatsu K; Ishii H; Takahashi G; Okamoto A; Moriyama M; Sakakura K; Masuyama K
Head Neck; 2012 Mar; 34(3):336-43. PubMed ID: 21472882
[TBL] [Abstract][Full Text] [Related]
19. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
[TBL] [Abstract][Full Text] [Related]
20. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.
Clay MR; Tabor M; Owen JH; Carey TE; Bradford CR; Wolf GT; Wicha MS; Prince ME
Head Neck; 2010 Sep; 32(9):1195-201. PubMed ID: 20073073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]